ClinicalTrials.gg
CompletedNCT05931588Updated Jul 5, 2023

Pilates Exercises on Postpartum Fatigue, Maternal Functioning and Quality of Life

An interventional study of Pilates excercises, streching and breathing and stretching and breathing in Maternal Fatigue, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-07-05.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The aim of the study is to determine the effect of Pilates exercises on postpartum fatigue, maternal functioning and quality of life.

Read the detailed description

the effect of Pilates exercises in reducing postpartum fatigue is not well known however in recent study Pilates exercises alone was quantified which was based on home exercises and had a positive effect, it was conducted in primiparas women, there was also possibility of recall bias due to self report nature of data

02

Conditions studied

  • Maternal Fatigue

Keywords

  • Pilates
  • maternal fatigue
  • maternal functioning
03

In context

Lead sponsor

Riphah International University is the lead sponsor of 2,176 studies on the registry; 637 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Multiparous females
  • Age 18 to 45 years
  • Females with vaginal delivery
  • Two weeks after Spontaneous Vaginal Delivery
  • Fatigue score of >11 on Fatigue Assessment scale

Exclusion criteria

Exclusion Criteria:

  • Postpartum depression score greater or equal to 10 , based on the Edinburgh Postnatal Depression scale (EPDS)
  • Postpartum anemia
  • Generalized Anxiety Disorders
  • Chronic illnesses (Diabetes /hypothyroidism)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Pilates exercises, streching and breathing

    the intervention Pilates exercises, streching and breathing exercises is administered under supervision

    Other: Pilates excercises, streching and breathing · Other: stretching and breathing

  • Experimental
    streching and breathing

    home based exercise program which is streching and breathing.

    Other: stretching and breathing

Interventions

  • OtherPilates excercises, streching and breathing

    international group receive Pilates exercises, stretching and breathing two times a week (30 min per session) perform 3 to 5 reps of Pilates exercises under supervision

  • Otherstretching and breathing

    control group guided with stretching and breathing home based program both group till 8 week both groups

06

What researchers measure

Primary outcomes

  1. postnatal maternal fatigue

    The Postnatal Accumulated Fatigue Scale (PAFS) (Tsuchiya et al., 2016) was once used to investigate maternal fatigue and included questions masking the three areas of physical, emotional and cognitive fatigue. The PAFS involves thirteen objects with every coded on a three-point response ranking the place zero = rarely, 1 = sometimes and three = often. Total rankings vary from zero to 39 with greater ratings indicating a greater stage of fatigue. The PAFS consists of questions overlaying three areas of physical, emotional, and cognitive fatigue and has top validity and interior consistency.

    Time frame: 8 Week

Secondary outcomes

  1. barkin indexmaternal functioning

    The BIMF used to be developed as a multidimensional instrument for measuring maternal functioning in each medical and research settings. It used to be designed in 2010 by way of Barkin et al. This instrument consists of 20 gadgets that cover all factors of maternal functioning, such as self-care, child care, mother-child interaction, household management, psychological well-being, adjustment, and social help.

    Time frame: 8 Week

  2. postnatal quality of life

    The Maternal Postpartum Quality of Life (MAPP-QOL) instrument consisted of 41 items. The instrument was intended to be completed by mothers during the early postpartum period following hospital discharge. The development of the instrument had two parts (satisfaction and importance) Part 1 queried the participant about her satisfaction with each item (1-6), with 1 = very dissatisfied and 6 =very satisfied. Part 2 queried about her level of importance with each item, 1 = very dissatisfied and 6 = very satisfied. Scores reflect individual values as well as satisfaction, producing a more accurate reflection of QOL.

    Time frame: 8 Week

Other outcomes

  1. generalized anxiety scale

    The 7-item Generalized Anxiety Disorders Scale (GAD-7; Spitzer) used to be developed as a screener for generalized anxiousness disease (GAD). The seven objects examine (1) feeling nervous, anxious, or on edge; (2) being in a position to quit or manipulate worrying; (3) stressful tool a whole lot about extraordinary things; (4) bother relaxing; (5) being restless; (6) turning into effortlessly aggravated or irritable; and (7) feeling afraid as if something awful may happen.

    Time frame: 8 Week

  2. • Edinburgh postnatal depression scale (EPDS)

    The EPDS was once delivered in 1987. When at first conceived, this 10-item self-report questionnaire was once designed for use in women in the postnatal period, for the purposes of clinical practice and research.

    Time frame: 8 Week

07

Study locations

1 site
  • Imrana nasir family clinic
    Rawalpindi, Punjab Province 25000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05931588
Responsible party
Sponsor
First posted
Jul 5, 2023
Start date
Dec 2, 2022
Primary completion
May 5, 2023
Completion
May 25, 2023
Last update
Jul 5, 2023

Study contacts

Summra Andleeb, MS(OMPT)
principal investigator · riphah internation university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion